glp-1 drugs for parkinson's disease Are we measuring the wrong primary outcome for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep The most extensive research to-date

A meta-analysis published in 2024 pooled data from 25 randomized controlled trials to assess the effects of taurine on risk factors related to metabolic syndrome (Tzang 2024)

What does the history of GLP-1 medications in the US look like

You have a pre-existing medical condition, such as liver or kidney disease

Malanotan II is used for tanning of the skin and producing of erections in men with erectile dysfunction when administered as a shot under the skin

Follicle-stimulating hormone (FSH) action on spermatogenesis: a focus on physiological and therapeutic roles

Capsule Stability S-acetyl and reduced-glutathione capsules may be easier to store, but they still require protection from heat, humidity, oxidation and manufacturing variability